skip navigation, go to content
Neuroprotection Exploratory Trials in Parkinson's Disease: NET-PD National Institute of Neurological Disorders and Stroke logo
National Institutes of Health
[What is the NET-PD Study?]
[Who is sponsoring NET-PD?]
[Enrolling now: FS-Zone]
[What other drugs are being studied?]
[Study publications]
[Privacy and confidentiality]
[En Espaņol]
[For more information, call toll free 1-800-352-9424 email or visit] Learn more about NET-PD clinical trials for Parkinson's Disease
[What is the NET-PD Study?]

NET-PD is a large multi-faceted effort to find drugs to slow the progression of Parkinson's disease. Like all U.S. clinical trials, NET-PD is carefully designed to answer questions about new drugs while safeguarding the health of volunteers.

How is NET-PD different from other studies?

Most PD treatment clinical trials focus on treating the symptoms of the disease. NET-PD evaluates agents that have the potential to slow the progression of PD.

What is a clinical trial?

A clinical trial is a study of the safety and efficacy of a new drug or other treatment. The NIH Exploratory Trials in Parkinson's Disease (NET-PD) will test several different compounds to learn if any of them can slow the progression of Parkinson's disease.

NET-PD Home | What is the NET-PD Study? | Who is sponsoring NET-PD? | Enrolling now: FS-Zone
What other drugs are being studied? | Study publications | Privacy and confidentiality | En Espaņol
NINDS Home | Download Adobe Reader

U.S. Department of Health and Human Services logo     National Institutes of Health logo logo

NIH...Turning Discovery Into Health®